Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis.

  title={Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis.},
  author={James D Kellner and Arne Ohlsson and Anne Gadomski and Elaine E. L. Wang},
  journal={Archives of pediatrics \& adolescent medicine},
  volume={150 11},
OBJECTIVE To determine if bronchodilators are efficacious in treating bronchiolitis. DATA SOURCES A search of bibliographic databases (MEDLINE, Excerpta Medica, and Reference Update) for bronchiolitis and albuterol or ipratropium bromide, or adrenergic agents or bronchodilator agents. Reference lists were also used. STUDY SELECTION Randomized, placebo-controlled trials of bronchodilator treatment in bronchiolitis were selected by 2 investigators. Fifteen of 89 identified publications met… 

Tables from this paper

Systemic Corticosteroids in Infant Bronchiolitis: A Meta-analysis

Combined, published reports of the effect of systemic corticosteroids on the course of bronchiolitis suggest a statistically significant improvement in clinical symptoms, LOS, and DOS.

Epinephrine for bronchiolitis.

There is insufficient evidence to support the use of epinephrine for the treatment of bronchiolitis among inpatients, and there is some evidence to suggest thatEpinephrine may be favourable to salbutamol and placebo among outpatients.

Bronchodilators for bronchiolitis.

Bronchodilators such as albuterol or salbutamol do not improve oxygen saturation, do not reduce hospital admission after outpatient treatment, doNot shorten the duration of hospitalization and do not shorten the time to resolution of illness at home.

Efficacy of Salbutamol and Ipratropium Bromide in the Management of Acute Bronchiolitis – A Clinical Trial

Clinical scores and oxygen saturation levels improved more rapidly in the bronchodilator groups than in the placebo group up to 24 h, but these drugs did not have a sufficient effect to change the natural course of the disease.

Short term effects of adrenaline in bronchiolitis: a randomised controlled trial

No improvement was shown with inhaled adrenaline in acute bronchiolitis, when compared with supportive care or placebo, as well as no further changes in any parameter in either treatment group at any assessment time after treatment.

Epinephrine for bronchiolitis.

This review demonstrates the superiority of epinephrine compared to placebo for short-term outcomes for outpatients, particularly in the first 24 hours of care.

Efficacy of oral dexamethasone in outpatients with acute bronchiolitis.

Outpatients with moderate-to-severe acute bronchiolitis derive significant clinical and hospitalization benefit from oral dexamethasone treatment in the initial 4 hours of therapy.

Oral salbutamol for symptomatic relief in mild bronchiolitis a double blind randomized placebo controlled trial.

Oral salbutamol is not superior to placebo in reducing the duration of symptoms in mild cases of acute bronchiolitis in children and frequency of hospitalization or adverse effects is not significant.

Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Epinephrine and Corticosteroid Therapy for Acute Bronchiolitis in Infants

Combination treatment of epinephrine and dexamethasone was effective in reducing hospital admission and length of stay among infants with bronchiolitis, but combined therapy was more effective at improving oxygen saturation level.



Efficacy of albuterol in the management of bronchiolitis.

Albuterol is as effective as oral placebo in the management of bronchiolitis and change in the state of the infant during the trial had significant effects on respiratory rate and clinical score.

Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial.

Inhaled bronchodilators did not improve the condition of hospitalised mild bronchiolitis and the change in oxygen saturation of recipients of both agents was significantly better than that of recipient of salbutamol alone or ipratropium bromide alone.

The efficacy of nebulized metaproterenol in wheezing infants and young children.

Although there appears to be an age-dependent degree of response, metaproterenol is effective in relieving the respiratory distress of young acutely wheezing children, including those with documented respiratory syncytial virus bronchiolitis.

Nebulized albuterol in acute bronchiolitis.

Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis.

The addition of ipratropium resulted in no additional benefit with respect to decrease in the respiratory rate, and the number of "nonresponders" and "clear responders" was also very similar in both groups.

Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis

It is concluded that corticosteroids do not change the rate of clinical improvement in acute bronchiolitis, nor do they effect lung function 2–4 weeks later.

Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers.

This study demonstrates that treatment with nebulised racemic adrenaline improved oxygenation and clinical signs in hospitalised children aged less than 18 months with bronchiolitis.